Filing Details
- Accession Number:
- 0000950170-25-030327
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-03 06:01:05
- Reporting Period:
- 2025-02-27
- Filing Date:
- 2025-03-03
- Accepted Time:
- 2025-03-03 06:01:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886744 | Geron Corp | GERN | Pharmaceutical Preparations (2834) | 752287752 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2035113 | James Ziegler | C/O Geron Corporation 919 E Hillsdale Blvd. Suite 250 Foster City CA 94404 | Evp, Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-27 | 100,000 | $1.60 | 100,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reported transaction represents the open market purchase of 100,000 shares at an executed price of $1.60 per share.